Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unclassifiable interstitial lung disease: a pathologist's perspective.

Kirk D Jones1

  • 1Dept of Pathology, University of California San Francisco, San Francisco, CA, USA kirk.jones@ucsf.edu.

European Respiratory Review : an Official Journal of the European Respiratory Society
|March 2, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deployment-Related Respiratory Health: Bridging the Gap between Clinical and Epidemiological Associations and Disease Mechanisms An Official American Thoracic Society Workshop Report.

Annals of the American Thoracic Society·2026
Same author

Novel BRAF fusion in Erdheim-Chester disease with pulmonary manifestations: Importance of RNA-based testing and response to MEK inhibition.

Histopathology·2026
Same author

Never Fear, the Robot Is Here: Robotic Resection for a Giant Thymoma.

Annals of thoracic surgery short reports·2025
Same author

Surgical lung biopsy analyses differ by race and ethnicity in interstitial lung disease.

ERJ open research·2025
Same author

Corrigendum to "A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers" [Lung Cancer 199 (2025) 108060].

Lung cancer (Amsterdam, Netherlands)·2025
Same author

A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers.

Lung cancer (Amsterdam, Netherlands)·2025
Same journal

Implementing acute exacerbations of COPD care bundles: evidence, effectiveness and future directions.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Preclinical human models of primary ciliary dyskinesia.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Bench evidence, bedside uncertainty: hyperoxia, mechanical ventilation and lung injury.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Respiratory support in paediatric patients with bronchiolitis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Air pollution-induced airway epithelial barrier dysfunction in COPD: a narrative review of mechanisms and therapeutic implications.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Utilising human cellular models of primary ciliary dyskinesia: a scoping review.

European respiratory review : an official journal of the European Respiratory Society·2026
See all related articles

Diagnosing pulmonary fibrotic disease aids treatment and prognosis. This study explores barriers to classifying interstitial lung disease and suggests strategies to improve diagnosis for better patient outcomes.

Area of Science:

  • Pulmonary Medicine
  • Pathology
  • Radiology

Background:

  • Accurate classification of pulmonary fibrotic diseases is crucial for guiding patient prognosis and treatment strategies.
  • Despite established histological, radiological, and clinical guidelines, a subset of patients presents with unclassifiable interstitial lung disease (ILD).

Purpose of the Study:

  • To investigate the challenges and barriers hindering the accurate classification of interstitial lung diseases.
  • To propose actionable strategies for overcoming these diagnostic obstacles and improving ILD classification.

Main Methods:

  • Review of existing literature on interstitial lung disease classification.
  • Analysis of common diagnostic challenges encountered in clinical practice.
  • Discussion of potential solutions and novel approaches to ILD diagnosis.

Related Experiment Videos

Main Results:

  • Several barriers impede ILD classification, including histological ambiguity, radiological pattern overlap, and limited clinical information.
  • The heterogeneity of fibrotic lung diseases contributes significantly to classification difficulties.
  • Current guidelines may not fully address the complexity of all ILD cases.

Conclusions:

  • Overcoming classification barriers in interstitial lung disease requires a multidisciplinary approach.
  • Implementing advanced diagnostic techniques and refining existing guidelines can enhance diagnostic accuracy.
  • Improved classification of ILD will lead to more personalized and effective patient management.